Sanofi Urges High Court To Expand Arthrex To All
Sanofi-Aventis has urged the U.S. Supreme Court to weigh in on its patent row with Mylan, arguing in a recent petition that the Federal Circuit's decision that the structure of the...To view the full article, register now.
Already a subscriber? Click here to view full article